Senthil Selvaraj

Conference European Journal of Heart Failure · June 29, 2026 AbstractBackgroundTransthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure (HF). Out ... Full text Cite

PROTEOMIC PATHWAY ANALYSIS YIELDS MECHANISTIC INSIGHTS INTO TREATMENT EFFECTS OF DAPAGLIFLOZIN VERSUS PLACEBO IN HFPEF: PRESERVED-HF

Conference JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 7, 2026 Link to item Cite

Abstract 4365864: Post-Discharge Outcomes and Healthcare Costs for Patients Hospitalized for Heart Failure with Transthyretin Amyloid Cardiomyopathy: Findings From GWTG–HF

Conference Circulation · November 4, 2025 Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is associated with high risk for heart failure (HF) hospitalization. However, little is known regarding post-discharge outcom ... Full text Cite

HOSPITAL-LEVEL VARIATION AND PREDICTIVE MODEL FOR TRANSTHYRETIN AMYLOID CARDIOMYOPATHY AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE

Conference JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 1, 2025 Link to item Cite

FUEL UTILIZATION DURING EXERCISE WITH EXOGENOUS KETONES VERSUS PLACEBO IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: KETO-HFPEF

Conference JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 1, 2025 Link to item Cite

Abstract 4116177: Metabolic and Pharmacokinetic Profiling of Ketone Ester by Background SGLT2 Inhibitor Therapy in Heart Failure with Reduced Ejection: A Phase I Clinical Trial

Conference Circulation · November 12, 2024 Background: Growing evidence supports a therapeutic role for ketones in HFrEF. However, no pharmacokinetic (PK) studies are available to guide further investigation, and uncertainty exists regarding u ... Full text Cite

METABOLIC EFFECTS OF DAPAGLIFLOZIN IN HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 2, 2024 Link to item Cite

METABOLIC EFFECTS OF DAPAGLIFLOZIN IN HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · 2024 Cite

Abstract 13276: Metabolic Pathways and Risk Biomarkers for Incident Heart Failure

Conference Circulation · November 7, 2023 Introduction: Metabolomic profiling provides important information about heart failure (HF) risk. Metabolites reporting on muscle fuel substrate including branched-chain amino acids (BCAAs) and ketone ... Full text Cite

Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals

Conference EUROPEAN JOURNAL OF HEART FAILURE · July 2023 Link to item Cite

Relationship of beta-hydroxybutyrate levels and ketosis duration with diagnostic FDG-PET studies performed for the evaluation of active cardiac sarcoidosis

Conference JOURNAL OF NUCLEAR MEDICINE · June 1, 2023 Link to item Cite

Phenome-Wide Association Study (phewas) Identifies Clinical Factors Associated With Plasma Ketones from Four Large Studies

Conference CIRCULATION · November 16, 2021 Link to item Cite

Endogenous versus Exogenous Ketosis to Suppress Myocardial Glucose Uptake on FDG-PET: KEETO-CROSS

Conference JOURNAL OF NUCLEAR MEDICINE · May 1, 2021 Link to item Cite

PULMONARY HYPERTENSION IS ASSOCIATED WITH A HIGHER RISK OF HEART FAILURE AND MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE: THE JACKSON HEART STUDY

Conference Journal of the American College of Cardiology · March 2017 Full text Cite